Amplitude completes debut acquisition with ClearBrain buyout

By Nikita Chaurasia  Date: 2020-03-11

Amplitude completes debut acquisition with ClearBrain buyout

Amplitude, a comprehensive product intelligence company, announced that it has acquired the software company ClearBrain to accelerate big product bets. The acquisition will enable customers of the company to estimate about the revenue growth driving features, product bets, and campaigns without extensive A/B testing. It will leverage ClearBrain’s technology and world-class engineering team to enhance its machine learning division.

The new division formed will be led by the CEO of ClearBrain, Bilal Mahmood. Both the companies have not disclosed the terms related to the deal yet.

Spenser Skates, CEO, Amplitude, reportedly stated that customers of the company use product intelligence to iterate rapidly on large bets and require instant clarity about the features & campaigns, which will drive the most user engagement. Several predictive analytics solutions provided to the companies are deceptive and not reliable because they show correlation as causation, however, ClearBrain has developed a self-serve, machine learning platform to offer predictive insights with effective out of the box, he further added.

Bilal Mahmood, Founder and CEO, ClearBrain, apparently stated that the opportunity to present predictive analytics in front of thousands of customers of Amplitude is an amazing proposition for the company. It is not often that firms find such a strong alignment in vision and culture with other firms, as ClearBrain has found with Amplitude, he further added.

For the record, Amplitude has continued to expand its business rapidly with a strong start in 2020. In the past few weeks, the company has increased its customer base by adding more than 2.5 trillion new user actions to its patented behavioral database, Nova, from thousands of products across the world. It has continuously expanded its customer base with market leaders in consumer marketplaces, SaaS, & others and also landed the global Fortune 100 financial service business.

Source credit:
https://amplitude.com/press/amplitude-acquires-clearbrain

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...